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We reports a case of a newly formed thrombus in the left atrial appendage during cardiopulmonary bypass detected 
by transesophageal echocardiography in a patient with chronic atrial fibrillation and mitral stenosis. This case alerts 
the anesthesiologists of possible thrombus formation despite full heparinization during cardiac surgery and the 
importance of a comprehensive echocardiography examination.  (Korean J Anesthesiol 2012; 62: 571-574)
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A cardiopulmonary bypass (CPB) is essential for valve 
surgery but is associated with extensive thrombin generation 
that cannot be prevented completely through anticoagulation 
with heparin [1,2]. We report a newly formed fresh left 
atrial appendage (LAA) thrombus detected during CPB 
under full heparinization by intraoperative transesophageal 
echocardiographic (TEE) monitoring in a patient with mitral 
stenosis (MS) undergoing a mitral valve replacement (MVR).
Case Report
A 65-year-old man, 163 cm in height and 60 kg in weight, 
was admitted to the emergency room with a cough, blood 
tinged sputum and dyspnea. He underwent percutaneous 
mitral balloon valvuloplasty 15 years earlier due to MS. He 
had a history of a cerebral infarction and hypertension. Elec-
trocardiography revealed atrial fibrillation (A-Fib). Minimal 
coronary artery occlusive disease was identified during 
coronary angiography. Transthoracic echocardiography (TTE) 
revealed severe MS (mitral valve area of 0.79 cm2; mean dia-
stolic pressure gradient of 12.5 mmHg; left atrial volume index 
[LAVI] of 115 ml/m2), mild tricuspid regurgitation, and a right 
ventricle systolic pressure of 47 mmHg and ejection fraction 
(EF) of 72%. Despite mild swirling in the left atrium (LA), no 
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mass or thrombi were observed. The patient was medicated 
with digoxin, torasemide, simvastatin, and 3 mg of warfarin. 
For MVR, warfarin was discontinued and heparinization was 
initiated four days before surgery until midnight of the day 
before surgery. The international normalized ratio (INR) and 
activated partial thromboplastin time (aPTT) one day before 
surgery were 1.00 and 26.3 seconds, respectively.
Before CPB, in TEE, severe spontaneous echo contrast (SEC) 
in the LA was noted with no evidence of thrombus at any angle 
(Fig. 1). CPB was instituted and after injecting 18000 units of 
heparin, the activated clotting time (ACT) was increased to 489 
seconds. During CPB, the ACT was maintained at more than 
500 seconds with an additional 3000 units of heparin. The body 
temperature was decreased to 33oC. The surgeon confirmed the 
absence of any removable organized thrombus in the LAA and 
performed MVR with a Carpentier-Edward 27 valve. 
After unclamping the aortic cross clamp (ACC), a well func-
tioning bioprosthetic mitral valve (MV) without para valvular 
leakage was confirmed through TEE. The pump flow rate was 
lowered to wean the patient from CPB and during de-airing of 
the heart, TEE revealed a newly formed non-mobile mass in 
the LAA (Fig. 2). At that time, the ACT was 569 seconds. After 
discussion with the surgeon, a re-bypass was planned, and the 
mass was removed via a left atriotomy after ACC. The clot was 
removed as a single piece, which measured approximately 33 × 
33 mm, which had the appearance of a fresh, newly formed 
thrombus by a visual inspection (Fig. 3). Weaning from the CPB 
was performed uneventfully. The total CPB and ACC time was 
81 minutes and 53 minutes, respectively. 
The patient awoke six hours after arriving at the intensive 
care unit with no neurological deficits and was extubated at 
postoperative day (POD) 1. Anticoagulation was started with 
warfarin at POD 2. He was transferred to the general ward at 
POD 3 and discharged at POD 9. His postoperative TTE revealed 
a well functioning bioprosthetic MV, a slightly decreased LA 
size with a normal LV function, and no remaining MS or mitral 
regurgitation.
Discussion
A LA thrombus may be a common finding in patients with 
A-Fib, MS, an enlarged LA, advanced age, or congestive heart 
failure [3]. The majority of thrombi are found within the LAA, 
pre operatively. In patients with MS and chronic A-Fib, the 
severity of SEC in the LA is strongly associated with a LA 
thrombus and recent embolic events [4]. On the other hand, 
the new development of a fresh thrombus during CPB under 
full heparinization, as observed in this case, is extremely rare 
and has not been reported before. The present case had the risk 
factors for the development of atrial thrombus: chronic A-Fib, 
Fig. 1. Transesophageal echocardiographic, midesophageal two-
chamber view before the initiation of cardiopulmonary bypass. There 
was spontaneous echo contrast (SEC) in the left atrium (LA) without 
evidence of a left atrial appendage (LAA) thrombus.
Fig. 2. Transesophageal echocardiographic, midesophageal two-
chamber view after mitral valve replacement during cardiopulmonary 
bypass. A newly formed thrombus was observed in the left atrial 
appendage (LAA). Fig. 3. Thrombus excised from the left atrial appendage.
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severe MS, enlarged LA and advanced age, but no evidence of 
thrombus was observed in the preoperative or intraoperative 
TEE before CPB. Furthermore, no organized thrombus was 
visible under a careful examination of the LAA by the surgeon 
after a left atriotomy. A visual inspection revealed the removed 
clot to have the appearance of a fresh, newly formed thrombus. 
CPB initiates extensive thrombin generation [2], which is 
only suppressed partially by the use of a high dose of heparin 
[1]. Contact of the blood with the extracorporeal circuit via 
the intrinsic coagulation pathway was reported to be the main 
contributor to thrombin generation [2]. In addition, the retran-
s fusion of highly thrombogenic blood aspirated from the 
pericardium and pleural space cavities during CPB promotes 
further systemic thrombin generation [5]. In the current case, 
it is unlikely that these etiologies contributed to thrombus 
formation because the pericardial blood was aspirated using 
a cell salvage device and was not reinfused to the patient until 
sternum closure.
One of the possible causes of thrombus in this case is 
heparin-induced thrombocytopenia (HIT), which occurs in 
approximately 1.9% of cardiac surgical patients [6]. The clinical 
features of HIT are a history of exposure to heparin, decreased 
platelet count of more than 50% from the baseline, and 
laboratory findings [7]. Although the patient in the present case 
used heparin during coronary angiography and after warfarin 
stopping before surgery, the preoperative and postoperative 
platelet counts were within the normal limits. Therefore, 
HIT may not the cause of the thrombus in the present case. 
Moreover, clot formation was limited to within the LAA, a 
feature that is different from previously reported cases of HIT-
induced thrombosis, which were massive and multiple in the 
intracavity [8] or CPB circuit [9]. 
After excluding HIT as the cause of the thrombus, the other 
possible cause is surgical trauma to the LAA. As TEE can provide 
false-negative results [10], it is advisable to inspect the LAA by 
the surgeon to confirm the absence of thrombi, particularly in 
patients with the above mentioned risk factors for atrial thrombi 
formation. This surgical trauma to the LAA could have triggered 
extensive thrombin generation and thrombus formation in the 
present case. Indeed, thrombus formation at the coronary sinus 
has been reported in MVR [11] and repair of the tetralogy of 
Fallot [12]. In these cases, surgical trauma to the coronary sinus 
was considered to be a possible cause of thrombosis. On the 
other hand, as the thrombus was detected after surgery in these 
cases, it is different from the present case of thrombus formed 
during CPB under full heparinization.
Regardless of the cause or location, a comprehensive TEE 
examination is still the best way of detecting intracardiac 
thrombi. TEE is the gold standard for the detection of LAA 
thrombi, with a 93-100% sensitivity and 99-100% specificity 
[13]. Although TEE has high sensitivity and specificity for the 
detection of LAA thrombi, false-negative results can occur 
because the LAA is normally multi-lobed, and a thrombus may 
be overlooked [10].
In this case, a newly formed LAA was observed during CPB 
under full heparinization, maintaining an ACT > 500 seconds by 
intraoperative TEE. Although the precise mechanism is unclear, 
this case shows that adequate ACT during CPB does not 
ensure the suppression of thrombus formation. This case also 
highlights the importance of routine serial and comprehensive 
intraoperative TEE during cardiac surgery because it prevented 
the patient from unexpected thromboembolic complications in 
the current case. 
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